Serrated polyposis syndrome (SPS) is the most common type of polyposis syndrome, affecting as many as one in every 250 persons undergoing screening colonoscopy. It
SPS
SPS
Serrated Polyposis Syndrome Remains Very Underdiagnosed by Community Endoscopists
Serrated Polyposis Syndrome Remains Very Underdiagnosed by Community Endoscopists
About Half of Cancers in Serrated Polyposis Syndrome Arise Through the Adenoma-Carcinoma Sequence
About Half of Cancers in Serrated Polyposis Syndrome Arise Through the Adenoma-Carcinoma Sequence
The serrated pathway of colorectal cancer (CRC) is considered to account for about 20% of all CRCs. Patients with serrated polyposis syndrome (SPS) have higher
Serrated Appendiceal Lesions Common in Serrated Polyposis but Not Clinically Important
Serrated Appendiceal Lesions Common in Serrated Polyposis but Not Clinically Important
Some previous work has suggested that the prevalence of advanced lesions in the appendix is high enough to warrant routine appendectomy in patients with serrated
Cancer Risk in Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesion Patients and Their Relatives
Cancer Risk in Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesion Patients and Their Relatives
This study used the Utah Cancer Registry to examine cancer risk in patients with serrated polyposis syndrome (SPS) and their relatives as well as patients
Estimating Cancer Risk in Serrated Polyposis Syndrome
Estimating Cancer Risk in Serrated Polyposis Syndrome
In a meta-analysis involving 36 studies and 2788 patients with serrated polyposis syndrome (SPS), the overall risk of colorectal cancer (CRC) was 19.9%. However, most
